Introduction

In the last decade, digital health has exploded. We’ve got things like electronic health records (EHR), telemedicine, virtual visits, and wearables revolutionising healthcare. And thanks to advanced tools like artificial intelligence (AI) and machine learning (ML), we can dive deep into big data. This is a huge deal for autoimmune diseases, especially the rare ones such as systemic lupus erythematosus.¹

The money flowing into digital health hit a whopping $21.6 billion in 2020, double what it was the year before. High-speed data transfer with 5G is opening even more doors.¹

This article explores how smart tech is shaking up the treatment of autoimmune diseases, including multiple sclerosis (MS), psoriatic arthritis (PsA), and systemic lupus erythematosus (SLE), all backed by solid scientific research.

Wearable technology for MS

Multiple sclerosis (MS) is a chronic autoimmune disease, a beast of a disease that messes with the central nervous system, causing everything from fatigue to cognitive changes. Wearable tech could be like having a personal health assistant, keeping tabs on everything, and stepping in when needed.

Types of wearables and their uses

There are all sorts of wearables for MS – think activity trackers, sensors, and even robotic exoskeletons. These gadgets track activity levels, fatigue, sleep, and disease progression.²

For example, pedometers and fitness trackers are commonly used by MS patients to track physical activity and sleep.^2,7

Benefits of wearable technology

Wearable technology has high potential, especially for those with multiple sclerosis (MS).²

• Continuous monitoring: These devices offer real-time data on your activity levels, fatigue, and even how long you’ve been sitting. It’s like having a personal health diary
• Patient empowerment: Wearables help patients understand their physical status better. It’s like having a coach that helps set goals and track your progress 
• Healthcare professional support: Many doctors love wearables for the remote data they provide, helping them make better clinical decisions and improve patient outcomes 

Challenges and barriers

Despite the potential benefits of wearable technology, the experience is not all sunshine and rainbows. Some patients feel anxious or frustrated with the constant monitoring. It can be overwhelming, like a strict regimen that’s hard to keep up with. And sometimes, the devices are just too complicated or poorly designed.²

Future directions

For wearables to shine, future designs should be more user-friendly, and privacy concerns must be addressed. With technology evolving, wearables could become as essential as a compass in navigating this complex disease.²

Smart tech in psoriatic arthritis treatment

Psoriatic arthritis (PsA) is a chronic autoimmune disease that can overlap with other rheumatological conditions, making it tricky to manage. However, smart tech, big data, and AI are turning this complex landscape into a navigable terrain.

Early detection and big data

Big epidemiological databases are a game-changer here. Institutions like the University of Toronto and Memorial University in Canada, along with sites in the UK, Sweden, and Italy have created repositories that store comprehensive biological and clinical data of PsA patients. These databases help researchers spot patterns and predictors for PsA, such as severe psoriasis, nail pitting, high BMI, and family history.³

Artificial intelligence and predictive modelling

AI is boosting the precision of PsA diagnosis and treatment. Using natural language processing (NLP), researchers combined structured and unstructured data from electronic medical records to identify 31 predictors for PsA, improving predictive accuracy to over 90%. Another study used machine learning to predict cardiovascular risk in PsA patients, outperforming traditional methods.^3,4

Wearable technology and patient monitoring

Wearables play a crucial role in continuous patient monitoring, tracking physical activity, sleep patterns, and vital signs. This real-time data helps healthcare providers manage PsA more effectively by detecting early signs of flare-ups or complications, enabling timely interventions.

The COVID-19 pandemic pushed telemedicine forward, showing its effectiveness in PsA management. A 2020 study found that telemedicine, including live video calls and online report sharing, was well-received by PsA patients, ensuring continuous care and reducing the need for in-person visits.³

Challenges and future directions

Despite the advancements, challenges remain. Data privacy and security are big concerns, and the complexity and usability of smart tech need improvement for wider adoption. Future research should tackle these issues and develop integrated, user-friendly platforms.

To wrap it up, smart tech could significantly enhance PsA treatment by improving early detection, personalised treatment, and continuous monitoring. Think of it like advanced tools solving a complex puzzle.

Machine learning in treating systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with various symptoms.

But what exactly is machine learning doing for lupus patients? Machine learning models (MLMs) can potentially improve lupus treatment, much like a sophisticated map guiding through a challenging landscape.

Early diagnosis and genetic markers

Machine learning (ML), a type of artificial intelligence (AI), helps us make sense of massive amounts of data. MLMs may aid early diagnosis and genetic marker identification significantly. Early diagnosis is vital for managing lupus effectively. For example, researchers used advanced algorithms in a study to pinpoint six specific proteins that can help diagnose SLE. These proteins correctly identified lupus patients 72% of the time compared to healthy individuals and 81% of the time to those with rheumatoid arthritis. Additionally, a set of nine proteins correctly identified SLE flare-ups almost every time and even more accurately.⁵

Categorising and grouping patients

One of the amazing things machine learning can do is group patients based on their symptoms and immune system features. For instance, a study in 2022 used machine learning to identify six key biomarkers for lupus, achieving impressive accuracy.^5,6

But what does this mean for patients? Essentially, these models can categorise patients based on their symptoms and immune system characteristics. This helps doctors predict which patients might have similar experiences with the disease. For example, one group might be at higher risk for kidney problems, while another might have more skin-related issues. By knowing this, doctors can customise treatment and monitoring plans to each group's specific needs, improving overall care and outcomes.⁵

Tailoring treatments with precision medicine

Machine learning also helps predict which treatments will work best for different patients. This is a type of precision medicine, meaning treatments can be more specifically targeted to each patient's unique genetic and immunological profile.⁵

Challenges and future directions

Of course, there are challenges. Machine learning models need large datasets to be accurate. Researchers must also ensure these models are easy for physicians to understand and use. Future research should focus on refining these models, integrating comprehensive datasets, and validating findings across diverse populations.⁵

Summary

Smart technology is transforming how we treat and manage autoimmune diseases like multiple sclerosis (MS), psoriatic arthritis (PsA), and systemic lupus erythematosus (SLE). These advancements may offer new ways to monitor health, predict disease progression, and personalise treatments.

Wearable technology for MS:

• Devices like fitness trackers can monitor activity, sleep, and fatigue
• Continuous monitoring acts like having a personal health diary, possibly offering real-time insights
• This could help doctors make better decisions and allow patients to manage their health more effectively
• However, some patients may find wearables overwhelming and hard to use

Smart tech in PsA Treatment:

• Large databases might help identify patterns and predictors of PsA onset
• AI could improve diagnosis and predict risks better than traditional methods
• Wearable devices and telemedicine may provide continuous care and reduce the need for in-person visits
• Challenges might include data privacy and the complexity of using these devices

Machine learning in SLE Treatment:

• Machine learning models (MLMs) can assist in diagnosing SLE early by identifying specific proteins
• These models could categorise patients based on their symptoms
• This might help doctors tailor treatments to individual needs, improving overall care
• Predicting how SLE will progress may allow for better planning and management
• Challenges could include the need for large datasets and making these models easy for doctors to use